This is the list of the largest public listed companies in the Biotechnology industry in the world by market capitalization with links to their reference stock.
Company Profile:
Anavex Life Sciences Corp.
Market Cap (USD):
$328.8 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
PharmaEngine, Inc.
Market Cap (USD):
$325.2 M
Country:
Taiwan
Sector:
Taiwanese Healthcare
Industry:
Taiwanese Biotechnology
Company Profile:
TCM Biotech International Corp
Market Cap (USD):
$325.2 M
Country:
Taiwan
Sector:
Taiwanese Healthcare
Industry:
Taiwanese Biotechnology
Company Profile:
Hansa Biopharma AB
Market Cap (USD):
$319.2 M
(July 1, 2024)
Country:
Sweden
Sector:
Swedish Healthcare
Industry:
Swedish Biotechnology
Company Profile:
Aclaris Therapeutics, Inc.
Market Cap (USD):
$312.0 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Genfit SA
Market Cap (USD):
$309.0 M
Country:
France
Sector:
French Healthcare
Industry:
French Biotechnology
Company Profile:
Essex Bio-Technology Ltd
Market Cap (USD):
$306.7 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Celon Pharma SA
Market Cap (USD):
$306.1 M
Country:
Poland
Sector:
Polish Healthcare
Industry:
Polish Biotechnology
Company Profile:
Allogene Therapeutics, Inc.
Market Cap (USD):
$303.4 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Taiwan Liposome Company, Ltd.
Market Cap (USD):
$302.9 M
(Sept. 1, 2021)
Country:
Taiwan
Sector:
Taiwanese Healthcare
Industry:
Taiwanese Biotechnology
Company Profile:
Oyster Point Pharma, Inc.
Market Cap (USD):
$299.9 M
(Dec. 1, 2022)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
TaiGen Biopharmaceuticals Holdings Ltd
Market Cap (USD):
$298.8 M
Country:
Taiwan
Sector:
Taiwanese Healthcare
Industry:
Taiwanese Biotechnology
Company Profile:
Oryzon Genomics SA
Market Cap (USD):
$298.2 M
Country:
Spain
Sector:
Spanish Healthcare
Industry:
Spanish Biotechnology
Company Profile:
Larimar Therapeutics, Inc.
Market Cap (USD):
$297.0 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Foghorn Therapeutics Inc.
Market Cap (USD):
$293.5 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Puma Biotechnology, Inc.
Market Cap (USD):
$290.8 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Abeona Therapeutics Inc.
Market Cap (USD):
$287.8 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Amarin Corporation plc
Market Cap (USD):
$285.3 M
Country:
Ireland
Sector:
Irish Healthcare
Industry:
Irish Biotechnology
Company Profile:
Cerecor Inc.
Market Cap (USD):
$285.0 M
(June 1, 2022)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Aldeyra Therapeutics, Inc.
Market Cap (USD):
$281.0 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Frontage Holdings Corp
Market Cap (USD):
$276.2 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Mabpharm Ltd
Market Cap (USD):
$275.5 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
SinoMab BioScience Ltd
Market Cap (USD):
$272.6 M
Country:
Hong Kong
Sector:
HK Healthcare
Industry:
HK Biotechnology
Company Profile:
Atea Pharmaceuticals, Inc.
Market Cap (USD):
$271.9 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Greenwich LifeSciences, Inc.
Market Cap (USD):
$269.7 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Immutep Limited
Market Cap (USD):
$266.4 M
(July 1, 2024)
Country:
Australia
Sector:
Australian Healthcare
Industry:
Australian Biotechnology
Company Profile:
Achieve Life Sciences, Inc.
Market Cap (USD):
$264.6 M
Country:
Canada
Sector:
Canadian Healthcare
Industry:
Canadian Biotechnology
Company Profile:
Imugene Limited
Market Cap (USD):
$264.1 M
(July 1, 2024)
Country:
Australia
Sector:
Australian Healthcare
Industry:
Australian Biotechnology
Company Profile:
Fennec Pharmaceuticals Inc.
Market Cap (USD):
$262.3 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Galectin Therapeutics, Inc.
Market Cap (USD):
$261.1 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology